$25.59
2.59%
Nasdaq, Jan 02, 10:00 pm CET

Fulgent Genetics Stock price

$25.59
-2.81 9.89% 1M
+5.49 27.31% 6M
-0.68 2.59% YTD
+7.17 38.93% 1Y
-4.19 14.07% 3Y
-33.71 56.85% 5Y
+16.41 178.76% 10Y
+16.41 178.76% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.68 2.59%

Key metrics

Basic
Market capitalization
$791.1m
Enterprise Value
$418.1m
Net debt
positive
Cash
$375.8m
Shares outstanding
30.9m
Valuation (TTM | estimate)
P/E
negative | 89.6
P/S
2.5 | 2.4
EV/Sales
1.3 | 1.3
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
92.9%
Return on Equity
-3.8%
ROCE
-6.2%
ROIC
-8.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$315.6m | $331.2m
EBITDA
$-63.0m | $-4.6m
EBIT
$-71.0m | $-25.5m
Net Income
$-43.0m | $8.8m
Free Cash Flow
$-19.9m
Growth (TTM | estimate)
Revenue
13.6% | 16.8%
EBITDA
22.0% | 93.0%
EBIT
19.9% | 65.5%
Net Income
73.9% | 120.6%
Free Cash Flow
30.8%
Margin (TTM | estimate)
Gross
41.2%
EBITDA
-20.0% | -1.4%
EBIT
-22.5%
Net
-13.6% | 2.7%
Free Cash Flow
-6.3%
More
EPS
$-1.4
FCF per Share
$-0.6
Short interest
10.4%
Employees
1k
Rev per Employee
$220.0k
Show more

Is Fulgent Genetics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Fulgent Genetics Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Fulgent Genetics forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Fulgent Genetics forecast:

Buy
78%
Hold
22%

Financial data from Fulgent Genetics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
316 316
14% 14%
100%
- Direct Costs 185 185
5% 5%
59%
130 130
29% 29%
41%
- Selling and Administrative Expenses 141 141
6% 6%
45%
- Research and Development Expense 52 52
7% 7%
16%
-63 -63
22% 22%
-20%
- Depreciation and Amortization 8 8
1% 1%
3%
EBIT (Operating Income) EBIT -71 -71
20% 20%
-22%
Net Profit -43 -43
74% 74%
-14%

In millions USD.

Don't miss a Thing! We will send you all news about Fulgent Genetics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fulgent Genetics Stock News

Neutral
Business Wire
12 days ago
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it has entered into a definitive agreement to acquire selected assets of Bako Diagnostics (“Bako”), a premier pathology laboratory headquartered in Alpharetta, GA and to ...
Neutral
Seeking Alpha
about 2 months ago
Fulgent Genetics, Inc. ( FLGT ) UBS Global Healthcare Conference 2025 November 10, 2025 5:00 PM EST Company Participants Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer Conference Call Participants Lu Li - UBS Investment Bank, Research Division Presentation Lu Li UBS Investment Bank, Research Division Great. Well, our next session is the management team from Fulge...
Neutral
Business Wire
about 2 months ago
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that members of its management team are scheduled to present at the following upcoming investor conferences: UBS Global Healthcare Conference on Monday, Nove...
More Fulgent Genetics News

Company Profile

Fulgent Genetics, Inc. operates as a technology company, which provides genetic testing and next generation sequencing solutions. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Head office United States
CEO Ming Hsieh
Employees 1,313
Founded 2016
Website www.fulgentgenetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today